Summary:
The goal of this study is to see if a treatment call fezolinetant is both effective and safe as a treatment for moderate to sever hot flashes associated with menopause.
Qualified Participants Must:
• Be between ages 40-65
• post menopausal
• have moderat to sever hot flashes
Qualified Participants May Receive:
All study related medical care at no cost; compensation up to $1700 for time and travel